Algo version: 0.98b
Suzhou Zelgen is listed at the SHH Exchange
Suzhou Zelgen [688266.SS]
SHH Sector: Healthcare Industry:Biotechnology

Is Suzhou Zelgen stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Suzhou Zelgen 10 years ago, but if you had invested on Thursday 23rd of January 2020 when the price was CNY74.59, you would have made a loss of CNY-4.39 per share or -5.89%

Yes, the average daily trading liquidity for Suzhou Zelgen is CNY2.27 million. You should therefore be able to get in and out of your positions relatively fast.

Suzhou Zelgen has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.03, the company's ability to pay off the debt is limited. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Suzhou Zelgen to be high [0.85 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.